Laser photocoagulation in patients with macular edema and diabetic retinopathy

Authors

Abstract

Introduction: by 2030 4.4 million diabetics could become blind due to retinopathy and macular edema. Its treatment is mainly based on laser photocoagulation.

Objective: to describe some demographic, clinical and surgical aspects in patients with diabetic retinopathy and macular edema treated with laser photocoagulation.

Methods: a cross-sectional descriptive study was carried out in 3 885 diabetics (6 515 eyes) treated at the Ciego de Ávila Ophthalmological Center between January 2014 and December 2019, who met the inclusion criteria. A data collection worksheet was created with the variables of interest. The data were taken from charge sheets, medical records and laser reports. The ethical precepts were fulfilled.

Results: type 2 diabetics (67,90 %), the 70 to 79-year-old group (31,22 %) and females (83,58 %) predominated. Clinically significant macular edema (55,32 %) and proliferative diabetic retinopathy without high-risk features (30,70 %) prevailed at initial diagnosis. At baseline, 1 875 right eyes and 1 706 left eyes presented visual acuity between 0,5 and 0,3. One year after treatment, there were 2 021 and 1 947, respectively; 97,00 % showed regression of the clinical picture. Hyperglycemia (13,67 %) was the most found non-regression factor. There were few complications (0,59 %).

Conclusions: visual acuity improved with laser photocoagulation. Although the majority of diabetics began in advanced stages, favorable indicators of clinical regression were achieved and complications were few

Downloads

Download data is not yet available.

Downloads

Published

2020-12-01

How to Cite

1.
Verona Ugando L, Mayea Díaz DY, Moreno González R, Sánchez Ortega D, Morffi González E, Hernández Conde M. Laser photocoagulation in patients with macular edema and diabetic retinopathy. Mediciego [Internet]. 2020 Dec. 1 [cited 2025 Dec. 5];26(4):e1672. Available from: https://revmediciego.sld.cu/index.php/mediciego/article/view/1672

Issue

Vol. 26 No. 4 (2020)

Section

Original article

License

Copyright (c) 2021 Leticia Verona Ugando

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):

You are free to:

  • Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.

The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.